Verheyen Patrick 4
4 · Cue Biopharma, Inc. · Filed Apr 13, 2023
Insider Transaction Report
Form 4
Verheyen Patrick
Director
Transactions
- Award
Stock Option (right to buy)
2023-04-11+40,000→ 40,000 totalExercise: $3.11Exp: 2033-04-10→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]This stock option grant becomes exercisable over three years with one-third vesting on the one-year anniversary of the grant date and the balance vesting in eight equal quarterly installments.